abstract |
A bicyclic compound represented by formula I, and tautomers, stereoisomers, hydrates, solvates, pharmaceutically acceptable salts, or prodrugs thereof; the bicyclic compound can be used for the treatment of EP2 and EP4 receptor-mediated diseases. |